English | Español
Patient Daily | Mar 16, 2026

American Lung Association releases report on community air monitoring and pollution response
Patient Daily | Mar 16, 2026

Eli Lilly announces $3 billion investment in China for obesity drug production
Patient Daily | Mar 16, 2026

Six companies announce job openings in Cambridge life sciences sector
Patient Daily | Mar 16, 2026

FDA to review Capricor's Duchenne therapy deramiocel with decision expected in August
Patient Daily | Mar 16, 2026

FDA official Vinay Prasad to depart as rare disease drug rejections draw scrutiny
Patient Daily | Mar 16, 2026

Senate hearing addresses FDA barriers to rare disease drug approvals
Patient Daily | Mar 16, 2026

FDA warns Novo Nordisk over unreported Ozempic safety events, including deaths
Patient Daily | Mar 16, 2026

Pharma faces fierce M&A competition as late-stage assets become scarce

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide